Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers

Resistance of progressive cancers against chemotherapy is a serious clinical problem. In this context, human epidermal growth factor receptor 3 (HER3) can play important roles in drug resistance to HER1- and HER2- targeted therapies. Since clinical testing of anti-HER3 monoclonal antibodies (mAbs) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Okita, Kouki, Okazaki, Shogo, Uejima, Shinya, Yamada, Erina, Kaminaka, Hiroki, Kondo, Misa, Ueda, Shiho, Tokiwa, Ryo, Iwata, Nami, Yamasaki, Akitaka, Hayashi, Natsumi, Ogura, Dai, Hirotani, Kenji, Yoshioka, Toshiaki, Inoue, Masahiro, Masuko, Kazue, Masuko, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967776/
https://www.ncbi.nlm.nih.gov/pubmed/32002122
http://dx.doi.org/10.18632/oncotarget.27414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967776/
https://www.ncbi.nlm.nih.gov/pubmed/32002122
http://dx.doi.org/10.18632/oncotarget.27414

Ejemplares similares